|
Delayed
Australian S.E.
18:59:13 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.0180 AUD | 0.00% |
|
0.00% | -70.49% |
| 09-29 | Vitura Health Limited Announces Resignation of Tom Howitt as Interim Chief Financial Officer, Effective 29 September 2026 | CI |
| 09-24 | Microba Life Sciences Appoints Interim CEO | MT |
| Market Cap | 11.93M 10.69M 9.86M 8.92M 16.68M 1.14B 16.95M 118M 46.92M 595M 44.77M 43.82M 1.88B | P/E 2025 |
11.4x | P/E 2026 | -3.77x |
|---|---|---|---|---|---|
| Enterprise Value | 22.98M 20.58M 18.99M 17.18M 32.13M 2.19B 32.65M 227M 90.36M 1.15B 86.23M 84.39M 3.63B | EV / Sales 2025 |
0.37x | EV / Sales 2026 | 0.21x |
| Free-Float |
27.99% | Yield 2025 |
3.23% | Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| VIT | Delayed | |
Deutsche Boerse AG
| 1CE0 | Delayed |
Last Transcript: Vitura Health Limited
| Current month | -7.69% | ||
| 1 month | -5.26% | ||
| 3 months | -30.77% | ||
| 6 months | -52.63% | ||
| Current year | -70.49% |
| 1 week | 0.02 |  | 0.02 |
| 1 month | 0.02 | | 0.02 |
| Current year | 0.02 | | 0.06 |
| 1 year | 0.02 | | 0.07 |
| 3 years | 0.02 | | 0.38 |
| 5 years | 0.02 | | 1.04 |
| 10 years | 0.02 | | 1.04 |
| Manager | Title | Age | Since |
|---|---|---|---|
Justin James
CEO | Chief Executive Officer | - | 2026-05-31 |
James Frayne
DFI | Director of Finance/CFO | - | 2026-09-28 |
Trudy Adams
CTO | Chief Tech/Sci/R&D Officer | - | 2026-08-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Iervasi
CHM | Chairman | - | 2024-02-12 |
Shane Tanner
CHM | Chairman | 72 | 2018-10-08 |
Rebecca Wilson
BRD | Director/Board Member | - | 2024-11-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/30/24 | Sell | Director | 3,500,000 | 0.6078% | ||
| 4/26/24 | Sell | Director | 10,000,000 | 1.7365% | ||
| 12/15/23 | Free | Chief Executive Officer | 1,241,808 | 0.2156% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -72.73% | -94.86% | 8.4M | |
| +6.63% | +5.13% | +68.86% | +145.20% | 1,148B | |
| +1.53% | +2.84% | +47.48% | +89.01% | 652B | |
| +1.68% | +1.96% | +29.16% | +109.31% | 505B | |
| +0.73% | +2.47% | +53.85% | +68.96% | 384B | |
| +3.83% | -0.62% | +69.01% | +42.32% | 348B | |
| +2.38% | +4.27% | +33.81% | +57.95% | 294B | |
| +2.26% | +3.47% | +5.21% | +28.92% | 264B | |
| +1.97% | +3.01% | +57.91% | +76.14% | 244B | |
| +4.03% | +5.36% | +39.76% | +116.14% | 197B | |
| Average | +2.11% | +1.84% | +33.23% | +63.91% | 403.72B | |
| Weighted average by Cap. | +2.25% | +1.50% | +50.22% | +95.97% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 124M 111M 102M 92.75M 173M 11.81B 176M 1.22B 488M 6.18B 465M 456M 19.58B | 131M 117M 108M 98.08M 183M 12.49B 186M 1.29B 516M 6.54B 492M 482M 20.7B |
| Net income | 3.32M 2.98M 2.75M 2.49M 4.65M 317M 4.72M 32.77M 13.07M 166M 12.48M 12.21M 525M | -4.39M -3.93M -3.63M -3.28M -6.14M -418M -6.24M -43.3M -17.27M -219M -16.48M -16.13M -693M |
| Net Debt | 4.39M 3.93M 3.63M 3.28M 6.14M 418M 6.24M 43.27M 17.26M 219M 16.47M 16.12M 693M | 11.05M 9.89M 9.13M 8.26M 15.45M 1.05B 15.7M 109M 43.45M 551M 41.46M 40.57M 1.74B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | A$0.0180 | 0.00% | 1,641 |
| 26-10-28 | A$0.0180 | -5.26% | 70,700 |
| 26-10-27 | A$0.0190 | +5.56% | 100,467 |
| 26-10-26 | A$0.0180 | +5.88% | 264,718 |
| 26-10-23 | A$0.0170 | -5.56% | 373 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIT Stock
Select your edition
All financial news and data tailored to specific country editions
